Experts explore data quality in cancer care

Laura Pedulli | | Health Exec | Quality

 

The Peer Exchange convened by The American Journal of Managed Care brought together payers and providers to hear their views on the value proposition of quality measures in oncology.

Leaders from Priority Health, Aetna, Humana, Cigna, Harvard Medical School and Dana-Farber Cancer Institute identified key quality measures in oncology and agreed that stakeholders have yet to reach consensus on the most critical and relevant measures to improve quality of patient care.

Read more below:

Panel Members Discuss Data Quality in Oncology Care

Laura Pedulli

Related Content

FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system
FDA commissioner urges health systems to strengthen AI quality oversight
The top 25 children's heart hospitals in the US
Study ranks US health system dead last among wealthy nations
The 25 top US hospitals for diabetes care
The 25 best heart hospitals in the United States

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Radiology Business
Policies and regulations shaping radiology in 2025

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.